Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Jan;38(1):33–39. doi: 10.1136/gut.38.1.33

Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

M John 1, W Meyerhof 1, D Richter 1, B Waser 1, J C Schaer 1, H Scherübl 1, J Boese-Landgraf 1, P Neuhaus 1, C Ziske 1, K Mölling 1, E O Riecken 1, J C Reubi 1, B Wiedenmann 1
PMCID: PMC1382976  PMID: 8566856

Abstract

Somatostatin receptor scintigraphy (SRS) is positive in approximately 75% of all patients with neuroendocrine gastroenteropancreatic tumours. This study aimed to identify specific somatostatin receptor (sstr) subtypes, which are responsible for the in vivo binding of the widely used somatostatin analogue, octreotide in human neuroendocrine gastroenteropancreatic tumours. Twelve patients underwent SRS with radiolabelled octreotide. After surgical resection, tumour tissues were analysed in vitro for somatostatin and octreotide binding sites by autoradiography. In addition, for the first time, sstr subtype mRNA expression was examined by semiquantitative reverse transcription polymerase chain reaction (RT-PCR). Tumour tissues from all SRS positive patients were positive by autoradiography. Semiquantitative RT-PCR revealed most prominently sstr2 expression in scintigraphically positive tumours. Two SRS negative tumours contained in vitro octreotide binding sites as well as high levels of sstr1 and sstr2 mRNAs. Positive SRS is mainly due to sstr2. sstr1, 3, 4, and probably 5 are less important for in vivo octreotide binding. False negative scintigraphic results seem to be influenced by factors independent of the expression of specific sstr.

Full text

PDF
33

Images in this article

37Figure 4
on p.37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruns C., Weckbecker G., Raulf F., Kaupmann K., Schoeffter P., Hoyer D., Lübbert H. Molecular pharmacology of somatostatin-receptor subtypes. Ann N Y Acad Sci. 1994 Sep 15;733:138–146. doi: 10.1111/j.1749-6632.1994.tb17263.x. [DOI] [PubMed] [Google Scholar]
  2. Chelly J., Kaplan J. C., Maire P., Gautron S., Kahn A. Transcription of the dystrophin gene in human muscle and non-muscle tissue. Nature. 1988 Jun 30;333(6176):858–860. doi: 10.1038/333858a0. [DOI] [PubMed] [Google Scholar]
  3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  4. Corness J. D., Demchyshyn L. L., Seeman P., Van Tol H. H., Srikant C. B., Kent G., Patel Y. C., Niznik H. B. A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides. FEBS Lett. 1993 Apr 26;321(2-3):279–284. doi: 10.1016/0014-5793(93)80124-d. [DOI] [PubMed] [Google Scholar]
  5. Demchyshyn L. L., Srikant C. B., Sunahara R. K., Kent G., Seeman P., Van Tol H. H., Panetta R., Patel Y. C., Niznik H. B. Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20. Mol Pharmacol. 1993 Jun;43(6):894–901. [PubMed] [Google Scholar]
  6. Dörr U., Wurm K., Höring E., Guzman G., Räth U., Bihl H. Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs. Horm Metab Res Suppl. 1993;27:36–43. [PubMed] [Google Scholar]
  7. Krenning E. P., Bakker W. H., Breeman W. A., Koper J. W., Kooij P. P., Ausema L., Lameris J. S., Reubi J. C., Lamberts S. W. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet. 1989 Feb 4;1(8632):242–244. doi: 10.1016/s0140-6736(89)91258-0. [DOI] [PubMed] [Google Scholar]
  8. Krenning E. P., Kwekkeboom D. J., Oei H. Y., de Jong R. J., Dop F. J., Reubi J. C., Lamberts S. W. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results. Ann N Y Acad Sci. 1994 Sep 15;733:416–424. doi: 10.1111/j.1749-6632.1994.tb17291.x. [DOI] [PubMed] [Google Scholar]
  9. Kubota A., Yamada Y., Kagimoto S., Shimatsu A., Imamura M., Tsuda K., Imura H., Seino S., Seino Y. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest. 1994 Mar;93(3):1321–1325. doi: 10.1172/JCI117090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kvols L. K., Brown M. L., O'Connor M. K., Hung J. C., Hayostek R. J., Reubi J. C., Lamberts S. W. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. Radiology. 1993 Apr;187(1):129–133. doi: 10.1148/radiology.187.1.8383865. [DOI] [PubMed] [Google Scholar]
  11. Lamberts S. W., Bakker W. H., Reubi J. C., Krenning E. P. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med. 1990 Nov 1;323(18):1246–1249. doi: 10.1056/NEJM199011013231805. [DOI] [PubMed] [Google Scholar]
  12. Lamberts S. W., Hofland L. J., van Koetsveld P. M., Reubi J. C., Bruining H. A., Bakker W. H., Krenning E. P. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab. 1990 Sep;71(3):566–574. doi: 10.1210/jcem-71-3-566. [DOI] [PubMed] [Google Scholar]
  13. Nocaudie-Calzada M., Huglo D., Deveaux M., Carnaille B., Proye C., Marchandise X. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide. J Nucl Med. 1994 Jan;35(1):57–62. [PubMed] [Google Scholar]
  14. Panetta R., Greenwood M. T., Warszynska A., Demchyshyn L. L., Day R., Niznik H. B., Srikant C. B., Patel Y. C. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Mol Pharmacol. 1994 Mar;45(3):417–427. [PubMed] [Google Scholar]
  15. Patel Y. C., Greenwood M. T., Warszynska A., Panetta R., Srikant C. B. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun. 1994 Jan 28;198(2):605–612. doi: 10.1006/bbrc.1994.1088. [DOI] [PubMed] [Google Scholar]
  16. Patel Y. C., Greenwood M., Kent G., Panetta R., Srikant C. B. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem Biophys Res Commun. 1993 Apr 15;192(1):288–294. doi: 10.1006/bbrc.1993.1412. [DOI] [PubMed] [Google Scholar]
  17. Ponte P., Ng S. Y., Engel J., Gunning P., Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 1984 Feb 10;12(3):1687–1696. doi: 10.1093/nar/12.3.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rens-Domiano S., Reisine T. Biochemical and functional properties of somatostatin receptors. J Neurochem. 1992 Jun;58(6):1987–1996. doi: 10.1111/j.1471-4159.1992.tb10938.x. [DOI] [PubMed] [Google Scholar]
  19. Reubi J. C., Häcki W. H., Lamberts S. W. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab. 1987 Dec;65(6):1127–1134. doi: 10.1210/jcem-65-6-1127. [DOI] [PubMed] [Google Scholar]
  20. Reubi J. C., Kvols L. K., Waser B., Nagorney D. M., Heitz P. U., Charboneau J. W., Reading C. C., Moertel C. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res. 1990 Sep 15;50(18):5969–5977. [PubMed] [Google Scholar]
  21. Reubi J. C., Laissue J., Waser B., Horisberger U., Schaer J. C. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues. Ann N Y Acad Sci. 1994 Sep 15;733:122–137. doi: 10.1111/j.1749-6632.1994.tb17262.x. [DOI] [PubMed] [Google Scholar]
  22. Reubi J. C., Maurer R., von Werder K., Torhorst J., Klijn J. G., Lamberts S. W. Somatostatin receptors in human endocrine tumors. Cancer Res. 1987 Jan 15;47(2):551–558. [PubMed] [Google Scholar]
  23. Reubi J. C., Schaer J. C., Waser B., Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res. 1994 Jul 1;54(13):3455–3459. [PubMed] [Google Scholar]
  24. Rohrer L., Raulf F., Bruns C., Buettner R., Hofstaedter F., Schüle R. Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4196–4200. doi: 10.1073/pnas.90.9.4196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Scherübl H., Bäder M., Fett U., Hamm B., Schmidt-Gayk H., Koppenhagen K., Dop F. J., Riecken E. O., Wiedenmann B. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology. 1993 Dec;105(6):1705–1709. doi: 10.1016/0016-5085(93)91066-q. [DOI] [PubMed] [Google Scholar]
  26. Wiedenmann B., Bäder H. M., Scherubl H., Fett U., Zimmer T., Hamm B., Koppenhagen K., Riecken E. O. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy. Semin Oncol. 1994 Oct;21(5 Suppl 13):29–32. [PubMed] [Google Scholar]
  27. Wulfsen I., Meyerhof W., Fehr S., Richter D. Expression patterns of rat somatostatin receptor genes in pre- and postnatal brain and pituitary. J Neurochem. 1993 Oct;61(4):1549–1552. doi: 10.1111/j.1471-4159.1993.tb13654.x. [DOI] [PubMed] [Google Scholar]
  28. Xu Y., Song J., Bruno J. F., Berelowitz M. Molecular cloning and sequencing of a human somatostatin receptor, hSSTR4. Biochem Biophys Res Commun. 1993 Jun 15;193(2):648–652. doi: 10.1006/bbrc.1993.1673. [DOI] [PubMed] [Google Scholar]
  29. Yamada Y., Kagimoto S., Kubota A., Yasuda K., Masuda K., Someya Y., Ihara Y., Li Q., Imura H., Seino S. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun. 1993 Sep 15;195(2):844–852. doi: 10.1006/bbrc.1993.2122. [DOI] [PubMed] [Google Scholar]
  30. Yamada Y., Post S. R., Wang K., Tager H. S., Bell G. I., Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):251–255. doi: 10.1073/pnas.89.1.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yamada Y., Reisine T., Law S. F., Ihara Y., Kubota A., Kagimoto S., Seino M., Seino Y., Bell G. I., Seino S. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol. 1992 Dec;6(12):2136–2142. doi: 10.1210/mend.6.12.1337145. [DOI] [PubMed] [Google Scholar]
  32. Zimmer T., Ziegler K., Bäder M., Fett U., Hamm B., Riecken E. O., Wiedenmann B. Localisation of neuroendocrine tumours of the upper gastrointestinal tract. Gut. 1994 Apr;35(4):471–475. doi: 10.1136/gut.35.4.471. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES